Oppenheimer analyst Suraj Kalia initiates coverage on Shockwave Medical (NASDAQ: SWAV) with a Perform rating.The analyst commented, "ShockWave’s intravascular lithotripsy ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE